Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

STSS

Sharps Technology (STSS)

Sharps Technology Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:STSS
FechaHoraFuenteTítuloSímboloCompañía
17/06/202407:30GlobeNewswire Inc.Sharps Technology Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Distribution Partner in ColombiaNASDAQ:STSSSharps Technology Inc
14/06/202412:40GlobeNewswire Inc.Join Sharps Technology’s Exclusive Live Investor Webinar and Q&A Session on June 18NASDAQ:STSSSharps Technology Inc
13/06/202407:30GlobeNewswire Inc.Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC FacilityNASDAQ:STSSSharps Technology Inc
05/06/202407:30GlobeNewswire Inc.Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow DepositNASDAQ:STSSSharps Technology Inc
31/05/202407:30GlobeNewswire Inc.Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.NASDAQ:STSSSharps Technology Inc
30/05/202407:30GlobeNewswire Inc.Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.NASDAQ:STSSSharps Technology Inc
28/05/202412:00GlobeNewswire Inc.Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured SyringesNASDAQ:STSSSharps Technology Inc
08/03/202415:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STSSSharps Technology Inc
07/03/202407:00GlobeNewswire Inc.Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery SystemsNASDAQ:STSSSharps Technology Inc
21/02/202420:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STSSSharps Technology Inc
21/02/202407:00GlobeNewswire Inc.Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in ColombiaNASDAQ:STSSSharps Technology Inc
16/02/202413:42GlobeNewswire Inc.Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery SystemsNASDAQ:STSSSharps Technology Inc
14/02/202410:14Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:STSSSharps Technology Inc
18/01/202408:00GlobeNewswire Inc.Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery SystemsNASDAQ:STSSSharps Technology Inc
14/11/202315:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STSSSharps Technology Inc
07/11/202307:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:STSSSharps Technology Inc
27/10/202315:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:STSSSharps Technology Inc
26/10/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:STSSSharps Technology Inc
16/10/202316:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:STSSSharps Technology Inc
29/09/202308:54GlobeNewswire Inc.Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private PlacementNASDAQ:STSSSharps Technology Inc
29/09/202307:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:STSSSharps Technology Inc
28/09/202309:52GlobeNewswire Inc.Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron PharmaceuticalsNASDAQ:STSSSharps Technology Inc
27/09/202311:03GlobeNewswire Inc.UPDATE - Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq RulesNASDAQ:STSSSharps Technology Inc
27/09/202308:14GlobeNewswire Inc.Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq RulesNASDAQ:STSSSharps Technology Inc
26/09/202307:30GlobeNewswire Inc.Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron PharmaceuticalsNASDAQ:STSSSharps Technology Inc
29/08/202315:15Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:STSSSharps Technology Inc
22/08/202315:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:STSSSharps Technology Inc
12/07/202307:33GlobeNewswire Inc.Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of SalesNASDAQ:STSSSharps Technology Inc
06/07/202306:50GlobeNewswire Inc.Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature ArticleNASDAQ:STSSSharps Technology Inc
26/05/202315:34Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:STSSSharps Technology Inc
 Showing the most relevant articles for your search:NASDAQ:STSS